MannKind Corp

MannKind Announces Exercise In Full of Over-Allotment Option and Completion of Public Offering of Units Consisting of Common Stock and Warrants to Purchase Common Stock

Stocks with implied volatility movement; MNKD S

MannKind to Present at Upcoming Conferences

Biotechnology Industry Starts Strong in 2012 -- MannKind and Celsion Look to Rally

24/7 Wall St. Closing Bell (MRO, PEET, RIMM, URBN, CHK, GILD, GNW, PCCC, NVLS, PKI, BEAM, EL, WY, THLD, TUDO, ZOLT, STRI, MNKD)

Mid-day Movers (THLD, OPTT, ZNGA, MNOV, MNKD)

Corrected: Gappers reports

MannKind falls 11.3%

Stocks with implied volatility movement; ZNGA MNKD

MannKind Receives Commitment from The Mann Group to Acquire 31,250,000 Shares of Common Stock

MannKind falls 12.9%

MannKind files to sell $50M in common stock and warrants

4 Biotech Stocks To Consider Buying, 2 To Sell In 2012

Stocks with implied volatility movement; ECA MNKD

Biotech Stock Mailbag: Celldex, Hep C Bubble, Al Mann Anger

MannKind CEO says it is in discussions about financing needs

MannKind says cash burn rate reduced to $10M-$12M per month

Stocks with implied volatility movement; NLY MNKD

MannKind to Present at 30th Annual J.P. Morgan Healthcare Conference

Here's What Some Big-Time Quants Are Buying

MannKind resolves all claims in arbitration with former employee

MannKind Resolves All Claims in Arbitration with Former Employee

Your Vote Counts: Who is the Worst Biotech CEO of 2011?

The Highest-Rated Biopharma Stocks

January Effect Boosting Stock Prices: Here Are the Possible Winners

MannKind to Present at Upcoming Conferences

From the Needle to the Pill: How Biotechnology Breakthough Can Help Patients, Doctors and Insurers Huge Costs (NAB,NAS:ORMP,MNKD)

MannKind Corporation Reports 2011 Third Quarter Financial Results

MannKind reports Q3 EPS (31c) vs. consensus (32c)

MannKind Corporation Reports 2011 Third Quarter Financial Results

Don't Bail on Biotech

Optimism on Diabetes Medication Grows -- MannKind and Amylin Benefit

MannKind Corporation to Hold 2011 Third Quarter Financial Results Conference Call on November 3, 2011

MannKind Corporation to Hold 2011 Third Quarter Financial Results Conference Call on November 3, 2011

Biotech Blunder Turned 20% Overnight Gain

Stocks with implied volatility movement; HGSI MNKD

MannKind option implied volatility low

MannKind to Present at The 18th Annual Newsmakers in the BioTech Industry Conference

Funding Security Critical to Long Term Success of Biotech Firms

5 Superball Stocks